Mark Thalgott

1.5k total citations
38 papers, 1.2k citations indexed

About

Mark Thalgott is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Cancer Research. According to data from OpenAlex, Mark Thalgott has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 11 papers in Surgery and 8 papers in Cancer Research. Recurrent topics in Mark Thalgott's work include Prostate Cancer Treatment and Research (22 papers), Prostate Cancer Diagnosis and Treatment (11 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Mark Thalgott is often cited by papers focused on Prostate Cancer Treatment and Research (22 papers), Prostate Cancer Diagnosis and Treatment (11 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Mark Thalgott collaborates with scholars based in Germany, United States and Canada. Mark Thalgott's co-authors include Jürgen E. Gschwend, Margitta Retz, Matthias Heck, Tobias Maurer, Roman Nawroth, Hubert Kübler, Matthias Eiber, Markus Schwaiger, Gregor Weirich and Sebastian C. Schmid and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and The FASEB Journal.

In The Last Decade

Mark Thalgott

37 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Thalgott Germany 21 758 324 284 252 233 38 1.2k
Simon Bott United Kingdom 19 994 1.3× 188 0.6× 156 0.5× 288 1.1× 197 0.8× 44 1.3k
Julie Steinestel Germany 19 473 0.6× 304 0.9× 81 0.3× 351 1.4× 229 1.0× 42 1.0k
Naoki Yanagawa Japan 22 949 1.3× 519 1.6× 226 0.8× 597 2.4× 281 1.2× 109 1.8k
Nabil Adra United States 19 622 0.8× 460 1.4× 139 0.5× 313 1.2× 757 3.2× 119 1.4k
Federica Recine Italy 19 441 0.6× 657 2.0× 65 0.2× 234 0.9× 246 1.1× 57 1.2k
Nicole Larrier United States 16 448 0.6× 159 0.5× 241 0.8× 222 0.9× 188 0.8× 38 934
Eugéniu Banu France 17 669 0.9× 471 1.5× 200 0.7× 369 1.5× 142 0.6× 45 1.3k
A. Kooistra Netherlands 12 576 0.8× 403 1.2× 95 0.3× 326 1.3× 110 0.5× 19 928
Barbara Vischioni Italy 18 440 0.6× 428 1.3× 125 0.4× 411 1.6× 247 1.1× 77 1.1k
Yves Denoux France 18 315 0.4× 545 1.7× 236 0.8× 510 2.0× 166 0.7× 43 1.3k

Countries citing papers authored by Mark Thalgott

Since Specialization
Citations

This map shows the geographic impact of Mark Thalgott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Thalgott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Thalgott more than expected).

Fields of papers citing papers by Mark Thalgott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Thalgott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Thalgott. The network helps show where Mark Thalgott may publish in the future.

Co-authorship network of co-authors of Mark Thalgott

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Thalgott. A scholar is included among the top collaborators of Mark Thalgott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Thalgott. Mark Thalgott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heck, Matthias, Margitta Retz, Gregor Weirich, et al.. (2018). Molecular Lymph Node Status for Prognostic Stratification of Prostate Cancer Patients Undergoing Radical Prostatectomy with Extended Pelvic Lymph Node Dissection. Clinical Cancer Research. 24(10). 2342–2349. 10 indexed citations
2.
Thalgott, Mark, Martina Kron, Donna P. Ankerst, et al.. (2017). Men with family history of prostate cancer have a higher risk of disease recurrence after radical prostatectomy. World Journal of Urology. 36(2). 177–185. 20 indexed citations
3.
Schwarzenböck, Sarah M., Michael Souvatzoglou, Jens Kurth, et al.. (2016). [11C]Choline PET/CT in therapy response assessment of a neoadjuvant therapy in locally advanced and high risk prostate cancer before radical prostatectomy. Oncotarget. 7(39). 63747–63757. 5 indexed citations
4.
Mücke, Thomas, Herbert Deppe, Klaus‐Dietrich Wolff, et al.. (2016). Prevention of bisphosphonate-related osteonecrosis of the jaws in patients with prostate cancer treated with zoledronic acid – A prospective study over 6 years. Journal of Cranio-Maxillofacial Surgery. 44(10). 1689–1693. 45 indexed citations
5.
6.
Thalgott, Mark, et al.. (2015). Diagnostic imaging of urolithiais. Current recommendations and new developments. Urologe A. 54(7). 948–955. 1 indexed citations
7.
Niegisch, Günter, Margitta Retz, Mark Thalgott, et al.. (2015). Second-Line Treatment of Advanced Urothelial Cancer with Paclitaxel and Everolimus in a German Phase II Trial (AUO Trial AB 35/09). Oncology. 89(2). 70–78. 24 indexed citations
8.
Horn, Thomas, Sebastian C. Schmid, Matthias Heck, et al.. (2015). Evaluation of Computed Tomography for Lymph Node Staging in Bladder Cancer Prior to Radical Cystectomy. Urologia Internationalis. 96(1). 51–56. 38 indexed citations
9.
Thalgott, Mark, Matthias Heck, Matthias Eiber, et al.. (2015). Circulating tumor cells versus objective response assessment predicting survival in metastatic castration-resistant prostate cancer patients treated with docetaxel chemotherapy. Journal of Cancer Research and Clinical Oncology. 141(8). 1457–1464. 19 indexed citations
10.
Thalgott, Mark, Matthias Heck, & Klaus Pantel. (2014). Detektion zirkulierender Tumorzellen im peripheren Blut beim Prostatakarzinom. Der Urologe. 53(4). 509–513. 1 indexed citations
11.
Sathe, Anuja, Ferdinand Guerth, Marcus V. Cronauer, et al.. (2014). Mutant PIK3CA controls DUSP1-dependent ERK 1/2 activity to confer response to AKT target therapy. British Journal of Cancer. 111(11). 2103–2113. 27 indexed citations
12.
Thalgott, Mark, Brigitte Rack, Tobias Maurer, et al.. (2013). Detection of circulating tumor cells in different stages of prostate cancer. Journal of Cancer Research and Clinical Oncology. 139(5). 755–763. 99 indexed citations
13.
Heck, Matthias, Michael Souvatzoglou, Margitta Retz, et al.. (2013). Prospective comparison of computed tomography, diffusion-weighted magnetic resonance imaging and [11C]choline positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer patients. European Journal of Nuclear Medicine and Molecular Imaging. 41(4). 694–701. 70 indexed citations
14.
15.
Heck, Matthias, et al.. (2012). Abiraterone- und Cabazitaxel-Härtefallprogramm. Der Urologe. 51(3). 390–397. 4 indexed citations
16.
Tauber, Robert, Sebastian C. Schmid, Thomas Horn, et al.. (2012). Inguinal lymph node dissection: Epidermal vacuum therapy for prevention of wound complications. Journal of Plastic Reconstructive & Aesthetic Surgery. 66(3). 390–396. 48 indexed citations
17.
Maurer, Tobias, Juan Antonio Aguilar‐Pimentel, Mark Thalgott, et al.. (2011). Immunostimulatory CpG-DNA and PSA-peptide vaccination elicits profound cytotoxic T cell responses. Urologic Oncology Seminars and Original Investigations. 31(7). 1395–1401. 10 indexed citations
18.
Maurer, Tobias, et al.. (2009). IMMUNOSTIMULATORY CPG-DNA AND PSA-PEPTIDE VACCINATION ELICITS PROFOUND CYTOTOXIC T CELL RESPONSES. The Journal of Urology. 181(4S). 185–185. 2 indexed citations
19.
Weckermann, Dorothea, Mark Thalgott, G. Höll, Theodor Wagner, & R. Harzmann. (2008). Radioguided surgery in urological malignancies. Indian Journal of Urology. 24(1). 4–4. 2 indexed citations
20.
Pfosser, Achim, Mark Thalgott, Agnès Brouet, et al.. (2004). Liposomal Hsp90 cDNA induces neovascularization via nitric oxide in chronic ischemia. Cardiovascular Research. 65(3). 728–736. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simon Bott Breakdown of academic impact, for papers by Julie Steinestel Breakdown of academic impact, for papers by Naoki Yanagawa Breakdown of academic impact, for papers by Nabil Adra Breakdown of academic impact, for papers by Federica Recine Breakdown of academic impact, for papers by Nicole Larrier Breakdown of academic impact, for papers by Eugéniu Banu Breakdown of academic impact, for papers by A. Kooistra Breakdown of academic impact, for papers by Barbara Vischioni Breakdown of academic impact, for papers by Yves Denoux
Rankless by CCL
2026